Navigation Links
ActX Bridges the Gap Between Better Patient Care and Current Physician Genetic Knowledge
Date:8/9/2018

ActX introduces GenoACT(sm), a Genetic Clinical Decision Support Service. The GenoACT service was developed and is continually updated by a talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by machine learning (AI). The integrated service provides:
1. Information on the medical impact of a patient’s genetic variants
2. Educational information for clinicians, with references
3. Actionable clinical recommendations to address the variants    

GenoACT covers the key clinically relevant areas of pharmacogenomics, hereditary risk and carrier status. Integrated into the Electronic Health Record (EHR), GenoACT blends seamlessly into normal workflow. By providing actionable information only as it is needed, GenoACT prevents the common problem of physician information overload. GenoACT actively checks prescriptions as they are written and identifies ineffective medications, potential adverse reactions, and dosing considerations. For actionable hereditary risk and carrier status, physicians are alerted in their normal clinical inbox initially and over time as new research uncovers potentially serious risks for all patient variants on file.

Most major EHR vendors (10 in total) have chosen to integrate the ActX Service within their EHRs. They have identified the value to health systems and physician practices of making precision medicine a core part of physician workflow, using the functionality of GenoACT.

Dr. Andrew Ury, founder of ActX explained: “As a working physician I recognized early in my career how difficult it was to stay on top of all the latest research. As Precision Medicine has evolved the clinical research on the use of a patient’s genetic variants has exploded and the knowledge gap has become a major stumbling block. By incorporating GenoACT into a clinician’s normal daily work flow, we have finally found a way to bridge this gap, through the use of up to date integrated, actionable, clinical decision support.”

About ActX:
Founded in 2012, ActX helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. Integrated into a physician’s normal software tools (the electronic medical record) and workflow, ActX analyzes the patient’s genetic information in real time and, for example, alerts the physician if a medication is unlikely to be effective or will cause side effects. ActX can also warn the physician about serious, actionable medical risks. For more information about ActX and taking the next step towards precision medicine, visit us at http://www.actx.com, contact us at info(at)actx.com or call 888-998-2289.

Read the full story at https://www.prweb.com/releases/actx_bridges_the_gap_between_better_patient_care_and_current_physician_genetic_knowledge/prweb15679107.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. SynCardia Total Artificial Heart Bridges Former Semi-Pro Arena Football Player to Heart Transplant
2. Autonomous energy-scavenging micro devices will test water quality, monitor bridges, more
3. SynCardia Total Artificial Heart Bridges Mother of Four with Congenital Heart Defect & Biventricular Heart Failure to Transplant
4. Single-Tooth Implants and Dental Bridges Market Worth $4,690 Million by 2019 - New Report by MarketsandMarkets
5. Dental Bridges and Single-Tooth Implants Market Hit to $4,690 Million by 2019 - New Research Report by MarketsandMarkets
6. Partnership between EBSCO Publishing and BioOne Online Journals Adds Scholarly Biological, Ecological and Environment Sciences Articles to EBSCO Discovery Service™
7. Probiotic Action Shares New Insight on the Link Between Sugar, Probiotics, and Acne
8. Probiotic Action Explains the New Link Between Probiotics, Bacteria and Eczema
9. Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers
10. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
11. Natural Acne Remedy, Probiotic Action Sheds Industry Insight on the Connection between Dairy and Acne
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... (PRWEB) , ... July 16, ... ... a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene ... Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space ...
(Date:7/9/2019)... ... , ... Today, at the BIO World Congress on Industrial Biotechnology ... announced the winners of the Consider Corn Challenge II. Three winners were chosen, each ... produce biobased materials. , “Corn is a sustainable, abundant and affordable industrial ...
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from preclinical ... Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical ... change in crystallite size , Over 142% increase in particle size , ...
(Date:6/12/2019)... ... June 12, 2019 , ... Leak Detection ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is excited to ... agreement will grant exclusive rights for Zillion to represent LDA in all of ...
Breaking Biology Technology:
(Date:6/19/2019)... ... ... Dahryn Trivedi, today released research results on the beneficial impact of biofield ... be beneficial for treating multiple bacterial diseases. , The preclinical trial shows:, ... decrease in weight , Over 8% alteration in melting point ...
(Date:6/13/2019)... ... , ... KICVentures announced today its plans to host an event ... ASC Conference in Chicago on Thursday, June 13th at 6:30 pm. The event will ... the 3rd floor Ticino Hospitality room in space #74T. , The event will feature ...
(Date:6/6/2019)... ... June 05, 2019 , ... Pelican BioThermal , ... station and service center in Mexico City, Mexico. Mexico is the second largest ... more than $1.75 billion in pharmaceutical exports since 2015. The Mexico City network ...
Breaking Biology News(10 mins):